213 related articles for article (PubMed ID: 34163162)
21. Co-Encapsulation of Combretastatin-A4 Phosphate and Doxorubicin in Polymersomes for Synergistic Therapy of Nasopharyngeal Epidermal Carcinoma.
Zhu J; Xu X; Hu M; Qiu L
J Biomed Nanotechnol; 2015 Jun; 11(6):997-1006. PubMed ID: 26353589
[TBL] [Abstract][Full Text] [Related]
22. Pharmacokinetic analysis of 111 in-labeled liposomal Doxorubicin in murine glioblastoma after blood-brain barrier disruption by focused ultrasound.
Yang FY; Wang HE; Liu RS; Teng MC; Li JJ; Lu M; Wei MC; Wong TT
PLoS One; 2012; 7(9):e45468. PubMed ID: 23029030
[TBL] [Abstract][Full Text] [Related]
23. SP94 peptide mediating highly specific and efficacious delivery of polymersomal doxorubicin hydrochloride to hepatocellular carcinoma in vivo.
Zhang J; Wang X; Cheng L; Yuan J; Zhong Z
Colloids Surf B Biointerfaces; 2021 Jan; 197():111399. PubMed ID: 33075660
[TBL] [Abstract][Full Text] [Related]
24. Efficient antiglioblastoma therapy in mice through doxorubicin-loaded nanomicelles modified using a novel brain-targeted RVG-15 peptide.
Han M; Xing H; Chen L; Cui M; Zhang Y; Qi L; Jin M; Yang Y; Gao C; Gao Z; Xing X; Huang W
J Drug Target; 2021 Nov; 29(9):1016-1028. PubMed ID: 33825602
[TBL] [Abstract][Full Text] [Related]
25. Lipopepsomes: A novel and robust family of nano-vesicles capable of highly efficient encapsulation and tumor-targeted delivery of doxorubicin hydrochloride in vivo.
Qiu M; Sun H; Meng F; Cheng R; Zhang J; Deng C; Zhong Z
J Control Release; 2018 Feb; 272():107-113. PubMed ID: 29355618
[TBL] [Abstract][Full Text] [Related]
26. Glioma-targeted dual functionalized thermosensitive Ferri-liposomes for drug delivery through an in vitro blood-brain barrier.
Shi D; Mi G; Shen Y; Webster TJ
Nanoscale; 2019 Aug; 11(32):15057-15071. PubMed ID: 31369016
[TBL] [Abstract][Full Text] [Related]
27. Targeted glioma chemotherapy by cyclic RGD peptide-functionalized reversibly core-crosslinked multifunctional poly(ethylene glycol)-b-poly(ε-caprolactone) micelles.
Fang Y; Jiang Y; Zou Y; Meng F; Zhang J; Deng C; Sun H; Zhong Z
Acta Biomater; 2017 Mar; 50():396-406. PubMed ID: 28065871
[TBL] [Abstract][Full Text] [Related]
28. VEGF-mediated tight junctions pathological fenestration enhances doxorubicin-loaded glycolipid-like nanoparticles traversing BBB for glioblastoma-targeting therapy.
Wen L; Tan Y; Dai S; Zhu Y; Meng T; Yang X; Liu Y; Liu X; Yuan H; Hu F
Drug Deliv; 2017 Nov; 24(1):1843-1855. PubMed ID: 29182025
[TBL] [Abstract][Full Text] [Related]
29. Systematic Evaluation of Transferrin-Modified Porous Silicon Nanoparticles for Targeted Delivery of Doxorubicin to Glioblastoma.
Luo M; Lewik G; Ratcliffe JC; Choi CHJ; Mäkilä E; Tong WY; Voelcker NH
ACS Appl Mater Interfaces; 2019 Sep; 11(37):33637-33649. PubMed ID: 31433156
[TBL] [Abstract][Full Text] [Related]
30. Tailoring Particle Size of Mesoporous Silica Nanosystem To Antagonize Glioblastoma and Overcome Blood-Brain Barrier.
Mo J; He L; Ma B; Chen T
ACS Appl Mater Interfaces; 2016 Mar; 8(11):6811-25. PubMed ID: 26911360
[TBL] [Abstract][Full Text] [Related]
31. Poly[N-(2-hydroxypropyl)methacrylamide]-Modified Magnetic γ-F
Plichta Z; Horák D; Mareková D; Turnovcová K; Kaiser R; Jendelová P
ChemMedChem; 2020 Jan; 15(1):96-104. PubMed ID: 31670889
[TBL] [Abstract][Full Text] [Related]
32. pH-sensitive degradable chimaeric polymersomes for the intracellular release of doxorubicin hydrochloride.
Du Y; Chen W; Zheng M; Meng F; Zhong Z
Biomaterials; 2012 Oct; 33(29):7291-9. PubMed ID: 22795540
[TBL] [Abstract][Full Text] [Related]
33. TRAIL and doxorubicin combination enhances anti-glioblastoma effect based on passive tumor targeting of liposomes.
Guo L; Fan L; Pang Z; Ren J; Ren Y; Li J; Chen J; Wen Z; Jiang X
J Control Release; 2011 Aug; 154(1):93-102. PubMed ID: 21609741
[TBL] [Abstract][Full Text] [Related]
34. Doxorubicin-polyglycerol-nanodiamond composites stimulate glioblastoma cell immunogenicity through activation of autophagy.
Li TF; Xu YH; Li K; Wang C; Liu X; Yue Y; Chen Z; Yuan SJ; Wen Y; Zhang Q; Han M; Komatsu N; Zhao L; Chen X
Acta Biomater; 2019 Mar; 86():381-394. PubMed ID: 30654213
[TBL] [Abstract][Full Text] [Related]
35. LRP1-mediated pH-sensitive polymersomes facilitate combination therapy of glioblastoma in vitro and in vivo.
He C; Zhang Z; Ding Y; Xue K; Wang X; Yang R; An Y; Liu D; Hu C; Tang Q
J Nanobiotechnology; 2021 Jan; 19(1):29. PubMed ID: 33482822
[TBL] [Abstract][Full Text] [Related]
36. Validation of Thiosemicarbazone Compounds as P-Glycoprotein Inhibitors in Human Primary Brain-Blood Barrier and Glioblastoma Stem Cells.
Salaroglio IC; Abate C; Rolando B; Battaglia L; Gazzano E; Colombino E; Costamagna C; Annovazzi L; Mellai M; Berardi F; Capucchio MT; Schiffer D; Riganti C
Mol Pharm; 2019 Aug; 16(8):3361-3373. PubMed ID: 31265310
[TBL] [Abstract][Full Text] [Related]
37. Cyclo(RGD)-Decorated Reduction-Responsive Nanogels Mediate Targeted Chemotherapy of Integrin Overexpressing Human Glioblastoma In Vivo.
Chen W; Zou Y; Zhong Z; Haag R
Small; 2017 Feb; 13(6):. PubMed ID: 27865044
[TBL] [Abstract][Full Text] [Related]
38. Enhanced intracellular delivery and chemotherapy for glioma rats by transferrin-conjugated biodegradable polymersomes loaded with doxorubicin.
Pang Z; Gao H; Yu Y; Guo L; Chen J; Pan S; Ren J; Wen Z; Jiang X
Bioconjug Chem; 2011 Jun; 22(6):1171-80. PubMed ID: 21528923
[TBL] [Abstract][Full Text] [Related]
39. Harnessing the cross-talk between tumor cells and tumor-associated macrophages with a nano-drug for modulation of glioblastoma immune microenvironment.
Li TF; Li K; Wang C; Liu X; Wen Y; Xu YH; Zhang Q; Zhao QY; Shao M; Li YZ; Han M; Komatsu N; Zhao L; Chen X
J Control Release; 2017 Dec; 268():128-146. PubMed ID: 29051064
[TBL] [Abstract][Full Text] [Related]
40. Improving glioblastoma therapeutic outcomes via doxorubicin-loaded nanomicelles modified with borneol.
Meng L; Chu X; Xing H; Liu X; Xin X; Chen L; Jin M; Guan Y; Huang W; Gao Z
Int J Pharm; 2019 Aug; 567():118485. PubMed ID: 31260781
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]